Actively Recruiting
Multi-center MRD Registry for Inflammatory Breast Cancer
Led by M.D. Anderson Cancer Center · Updated on 2025-11-06
200
Participants Needed
1
Research Sites
369 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
CONDITIONS
Official Title
Multi-center MRD Registry for Inflammatory Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female or males 18 years of age or older who can understand and sign a written consent
- Clinical diagnosis of stage III or IV inflammatory breast cancer
- Planning to have or have completed at least one blood draw for Signatera MRD testing with results and clinical data available
- Within eight months of diagnosis and have not had breast surgery for this breast cancer
- English-speaking participants
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
S
Sadia Saleem, MD
CONTACT
A
Angela Alexander
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here